AU9426198A - Azetidinone derivatives for the treatment of hcmv infections - Google Patents

Azetidinone derivatives for the treatment of hcmv infections

Info

Publication number
AU9426198A
AU9426198A AU94261/98A AU9426198A AU9426198A AU 9426198 A AU9426198 A AU 9426198A AU 94261/98 A AU94261/98 A AU 94261/98A AU 9426198 A AU9426198 A AU 9426198A AU 9426198 A AU9426198 A AU 9426198A
Authority
AU
Australia
Prior art keywords
lower alkyl
phenyl
het
optionally substituted
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU94261/98A
Other languages
English (en)
Inventor
Catherine Chabot
Robert Deziel
Stephen Kawai
Jeffrey O'meara
William W. Ogilvie
Christiane Yoakim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim (Canada) Ltd
Original Assignee
Boehringer Ingelheim (Canada) Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim (Canada) Ltd filed Critical Boehringer Ingelheim (Canada) Ltd
Publication of AU9426198A publication Critical patent/AU9426198A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AU94261/98A 1997-10-07 1998-10-06 Azetidinone derivatives for the treatment of hcmv infections Abandoned AU9426198A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6154897P 1997-10-07 1997-10-07
US60061548 1997-10-07
PCT/CA1998/000954 WO1999018073A1 (en) 1997-10-07 1998-10-06 Azetidinone derivatives for the treatment of hcmv infections

Publications (1)

Publication Number Publication Date
AU9426198A true AU9426198A (en) 1999-04-27

Family

ID=22036473

Family Applications (1)

Application Number Title Priority Date Filing Date
AU94261/98A Abandoned AU9426198A (en) 1997-10-07 1998-10-06 Azetidinone derivatives for the treatment of hcmv infections

Country Status (10)

Country Link
US (1) US6211170B1 (cg-RX-API-DMAC10.html)
EP (1) EP1023265B1 (cg-RX-API-DMAC10.html)
JP (1) JP2001519330A (cg-RX-API-DMAC10.html)
AT (1) ATE231124T1 (cg-RX-API-DMAC10.html)
AU (1) AU9426198A (cg-RX-API-DMAC10.html)
CA (1) CA2301967C (cg-RX-API-DMAC10.html)
DE (1) DE69810800T2 (cg-RX-API-DMAC10.html)
DK (1) DK1023265T3 (cg-RX-API-DMAC10.html)
ES (1) ES2187064T3 (cg-RX-API-DMAC10.html)
WO (1) WO1999018073A1 (cg-RX-API-DMAC10.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA91341C2 (ru) 2004-07-15 2010-07-26 Амр Текнолоджи, Інк. Арил- и гетероарилзамещенные тетрагидроизохинолины и их применение для блокирования обратного захвата норэпинефрина, допамина и серотонина
GB0608899D0 (en) * 2006-05-05 2006-06-14 Leuven K U Res & Dev Novel viral replication inhibitors
ES2428326T3 (es) * 2007-10-04 2013-11-07 Merck Sharp & Dohme Corp. Derivados de aril sulfona sustituida como bloqueadores de canales de calcio
US9156812B2 (en) 2008-06-04 2015-10-13 Bristol-Myers Squibb Company Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
JP5739415B2 (ja) 2009-05-12 2015-06-24 ブリストル−マイヤーズ スクウィブ カンパニー (S)−7−([1,2,4]トリアゾロ[1,5−a]ピリジン−6−イル)−4−(3,4−ジクロロフェニル)−1,2,3,4−テトラヒドロイソキノリンの結晶形態およびその使用
CN102595902B (zh) * 2009-05-12 2015-04-29 阿尔巴尼分子研究公司 7-([1,2,4]三唑并[1,5-a]吡啶-6-基)-4-(3,4-二氯苯基)-1,2,3,4-四氢异喹啉及其用途
ES2446971T3 (es) 2009-05-12 2014-03-11 Albany Molecular Research, Inc. Tetrahidroisoquinolinas sustituidas con arilo, heteroarilo, y heterociclo y su uso
WO2014055644A2 (en) * 2012-10-02 2014-04-10 New York University Pharmaceutical compositions and treatment of genetic diseases associated with nonsense mediated rna decay
US11072610B2 (en) 2018-09-12 2021-07-27 Novartis Ag Antiviral pyridopyrazinedione compounds
CN114667285B (zh) 2019-09-26 2025-08-08 诺华股份有限公司 抗病毒吡唑并吡啶酮化合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4680391A (en) 1983-12-01 1987-07-14 Merck & Co., Inc. Substituted azetidinones as anti-inflammatory and antidegenerative agents
US5229381A (en) 1983-12-01 1993-07-20 Merck & Co., Inc. Substituted azetidinones as anti-inflammatory and antidegenerative agents
NZ228600A (en) * 1988-04-11 1992-02-25 Merck & Co Inc 1-(benzylaminocarbonyl)-4-phenoxy-azetidin-2-one derivatives
DE377549T1 (de) 1989-01-03 1990-11-08 Marcos Y. Southbridge Mass. Kleinerman Fernmessung physikalischer variablen mit faseroptischen systemen.
US5104862A (en) 1991-03-20 1992-04-14 Merck & Co., Inc. Bethalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone
US5100880A (en) 1991-03-20 1992-03-31 Merck & Co., Inc. Novel betalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone
GB2266527A (en) 1992-03-17 1993-11-03 Merck & Co Inc Substituted azetidinones useful in the treatment of leukemia
GB9314350D0 (en) * 1993-07-12 1993-08-25 Zeneca Ltd Armide derivatives
HUT75660A (en) * 1994-03-23 1997-05-28 Tokyo Tanabe Co Novel remedy for respiratory-tract viral disease

Also Published As

Publication number Publication date
WO1999018073A1 (en) 1999-04-15
DE69810800T2 (de) 2003-09-18
DE69810800D1 (de) 2003-02-20
JP2001519330A (ja) 2001-10-23
EP1023265A1 (en) 2000-08-02
EP1023265B1 (en) 2003-01-15
CA2301967C (en) 2005-05-17
US6211170B1 (en) 2001-04-03
ATE231124T1 (de) 2003-02-15
ES2187064T3 (es) 2003-05-16
CA2301967A1 (en) 1999-04-15
DK1023265T3 (da) 2003-02-24

Similar Documents

Publication Publication Date Title
ATE222894T1 (de) Substituierte aminophenylisoxazolinderivate verwendbar als antimikrobielle agenzien
CA2224438A1 (en) Vinyl-pyrrolidinone cephalosporins with basic substituents
CA2301543A1 (en) Azetidinone derivatives for the treatment of hcmv infections
AU2910600A (en) Phenyl urea and phenyl thiourea derivatives
DE60005504D1 (de) Chinolinderivate als mek enzym-inhibitoren
MY104652A (en) A spiro compound
DK1023265T3 (da) Azetidinonderivater til behandlingen af HCMV infektioner
TW342385B (en) Bicyclic benzazepin, the process for their preparation and the pharmaceutical composition containing them
AU9425998A (en) Azetidinone derivatives for the treatment of hcmv infections
CA2221689A1 (en) Anti-ischaemic hydroxylamine derivatives and pharmaceutical compositions
MX9708422A (es) Esteres de carbapenemas.
CA2272136A1 (en) Pyrazole derivatives having crf antagonist activity
EP0273357A3 (en) Fluorine-containing macrolide compounds, pharmaceutical compositions comprising the same and their use for the manufacture of medicaments

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase